Assuming patients is required, the following results were found.

  • Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

    I and II, ofatumumab (OMB157) met primary endpoints to reduce the annualized relapse rate over Aubagio®*(teriflunomide) in patients with relapsing forms of MS (RMS)[1] Key secondary endpoints of delaying time to confirmed disability progression were...

    https://mschristian.org/index.php/blog/novartis-ofatumumab-demonstrates-superiority-versus-aubagio-in-two-head-to-head-phase-iii-multiple-sclerosis-studies
  • #ECTRIMS2019 - Longer DMT Use and Female Sex Seen to Protect Against SPMS Conversion - Multiple Sclerosis News Today

    to secondary progressive multiple sclerosis (SPMS) than others, according to a study based on the Italian MS registry. But patients whose disease starts after age 40, have a multifocal onset (multiple lesions and symptoms), greater disability at MS...

    https://mschristian.org/index.php/blog/ectrims2019-longer-dmt-use-and-female-sex-seen-to-protect-against-spms-conversion-multiple-sclerosis-news-today
  • Multiple sclerosis: Perilous ruptures

    Date:Source:Ludwig-Maximilians-Universität MünchenSummary:The permanent neurological deficits of multiple sclerosis patients largely depend on the extent of degeneration of long nerve fibers. The latter is initiated by ruptures in the cell membrane and...

    https://mschristian.org/index.php/blog/multiple-sclerosis-perilous-ruptures
  • Food allergies and multiple sclerosis: New link

    sclerosis. The results are published in the Journal of Neurology, Neurosurgery & Psychiatry. "Some multiple sclerosis patients with significant allergies would complain of frequent relapses associated with their allergic episodes," said Tanuja Chitnis,...

    https://mschristian.org/index.php/blog/food-allergies-and-multiple-sclerosis-new-link
  • NIH trial aims to improve drug discovery for ischemic stroke

    and Stroke (NINDS), Walter Koroshetz, says the main goal is to identify the most promising treatments for testing in patients who have entered clinical trials. In the long term, we hope that this approach will increase the chance of success in pairing a...

    https://mschristian.org/index.php/blog/nih-trial-aims-to-improve-drug-discovery-for-ischemic-stroke
  • Aubagio (teriflunomide)

    warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that may be dangerous. Severe liver damage. Aubagio can cause severe liver problems, including liver...

    https://mschristian.org/index.php/blog/aubagio-teriflunomide
  • Central Michigan Hospital plots leadership path in MS research (Blood testing for MS, NeuroFilaments and more)

    Memorial Healthcare's neurology department is growing and engaged in cutting-edge research New blood tests for MS patients are being tested that will help doctors pinpoint stage of disease and best drug to slow debilitating effects Multi-disciplinary...

    https://mschristian.org/index.php/blog/central-michigan-hospital-plots-leadership-path-in-ms-research-blood-testing-for-ms-neurofilaments-and-more
  • Dark Rimmed Brain Lesions May Be Signal of Aggressive Disease, NIH Study Says

    report. Using a powerful MRI brain scanner and a 3D printer, the team visualized brain images from nearly 200 MS patients and found that these spots — identified as chronic active lesions — may be used to signal people at a higher risk of more...

    https://mschristian.org/index.php/blog/dark-rimmed-brain-lesions-may-be-signal-of-aggressive-disease-nih-study-says
  • Stroke drug may also prevent Alzheimer's disease

    University PressSummary:Researchers have discovered that a drug currently being developed to treat stroke patients could also prevent Alzheimer's disease. The study shows that the genetically engineered protein 3K3A-APC protects the brains of mice with...

    https://mschristian.org/index.php/blog/stroke-drug-may-also-prevent-alzheimer-s-disease
  • Food allergies linked to increased disease activity in multiple sclerosis

    Food allergies are associated with heightened levels of disease activity in patients with multiple sclerosis (MS), shows research published online in the Journal of Neurology Neurosurgery & Psychiatry. Allergic patients had more relapses and greater...

    https://mschristian.org/index.php/blog/food-allergies-linked-to-increased-disease-activity-in-multiple-sclerosis
  • Alcohol Consumption Linked to Lower MS Disability

    By: Alicia Ciccone Alcohol Consumption Linked to Lower MS Disability WASHINGTON — Multiple sclerosis patients who consumed larger amounts of alcohol had lower rates of disability per the Expanded Disability Status Score (EDSS) and Multiple Sclerosis...

    https://mschristian.org/index.php/blog/alcohol-consumption-linked-to-lower-ms-disability
  • Murder, Favor, or Neither? Remicade Double-Billing; Illegal Butt Lifts

    other people. Pharmacists at the supermarket where she filled the prescriptions grew suspicious when two of the supposed patients were male. It's not entirely clear what the physician did with the drugs. (Miami Herald) A Long Island, New York, family...

    https://mschristian.org/index.php/blog/murder-favor-or-neither-remicade-double-billing-illegal-butt-lifts
  • Our vulnerable nervous system: What affects its protective sheaths?

    discovered how the formation of myelin sheaths is regulated by protein molecules. This knowledge could be used to help MS patients by stimulating the formation of new myelin sheaths after a relapse. The human brain is likened to a high-performance...

    https://mschristian.org/index.php/blog/our-vulnerable-nervous-system-what-affects-its-protective-sheaths
  • Northwestern Medicine study finds that stem cell transplants can reverse autoimmune diseases - The Daily Northwestern

    is capable of reversing autoimmune diseases like neuromyelitis optica, an aggressive neurological disease that causes many patients to lose their sight and ability to walk within five years following diagnosis. Formerly classified as a subtype of...

    https://mschristian.org/index.php/blog/northwestern-medicine-study-finds-that-stem-cell-transplants-can-reverse-autoimmune-diseases-the-daily-northwestern
  • Research Project 3TR To Use Breath Biopsy, Improve Immune-mediated Disease Management - Technology Networks

    Under the initiative, 3TR will have access to an unprecedented quantity of clinical data and samples of more than 50,000 patients across 50 ongoing and new clinical trials, ultimately aiming to discover and verify stratification biomarkers to improve...

    https://mschristian.org/index.php/blog/research-project-3tr-to-use-breath-biopsy-improve-immune-mediated-disease-management-technology-networks
  • Trending News Today: FDA Accepts NDA for Topical Rosacea Treatment - Pharmacy Times

    Prescription Drug User Fee Act action date, the article reported. A new study found that the risk of serious infection for patients with multiple sclerosis (MS) varies depending on their treatment, The American Journal of Managed Care reported....

    https://mschristian.org/index.php/blog/trending-news-today-fda-accepts-nda-for-topical-rosacea-treatment-pharmacy-times
  • Sanofi and Happify Health solidify collaboration around prescription DTx designed to address mental health in people with MS

    major depression at a rate two to five times higher than the general population, depending on the country studied. “Many patients with MS face significant burdens, and we have an obligation to help them not only maximize their physical health, but their...

    https://mschristian.org/index.php/blog/sanofi-and-happify-health-solidify-collaboration-around-prescription-dtx-designed-to-address-mental-health-in-people-with-ms
  • Clinical Challenges: MS and Pregnancy | Medpage Today - MedPage Today

    It wasn't so long ago that clinicians counseled patients with multiple sclerosis against pregnancy in the belief that it would make their MS worse. That view has since proved demonstrably incorrect, thanks to studies such as one published in the New...

    https://mschristian.org/index.php/blog/clinical-challenges-ms-and-pregnancy-medpage-today-medpage-today
  • NIH trial aims to improve drug discovery for ischemic stroke

    and Stroke (NINDS), Walter Koroshetz, says the main goal is to identify the most promising treatments for testing in patients who have entered clinical trials. In the long term, we hope that this approach will increase the chance of success in pairing a...

    https://mschristian.org/index.php/articles/2-uncategorised/8454-nih-trial-aims-to-improve-drug-discovery-for-ischemic-stroke
  • Multiple sclerosis drug slows brain shrinkage, study finds

    to investigate whether ibudilast was better than placebo in reducing the progression of brain atrophy, or shrinkage, in patients with progressive multiple sclerosis. In the study, 255 patients were randomized to take up to 10 capsules of ibudilast or...

    https://mschristian.org/index.php/articles/2-uncategorised/4405-multiple-sclerosis-drug-slows-brain-shrinkage-study-finds

Results 161 - 180 of 484